GE HealthCare said it is cooperating with reviews by the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) into potential violations of the Foreign Corrupt Practices Act (FCPA) in China.
GE Healthcare disclosed the matter in a regulatory filing Tuesday. It said it voluntarily self-reported to the agencies beginning in 2018 regarding “tender irregularities and other potential violations of the FCPA relating to our activities in certain provinces in China.”
